GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Price-to-Funds-From-Operations

Acticor Biotech (XPAR:ALACT) Price-to-Funds-From-Operations : (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.